Aubagio and Reglan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aubagio (teriflunomide) and Reglan (metoclopramide hydrochloride). Common drug interactions include multiple sclerosis relapse among females.

The phase IV clinical study analyzes what interactions people have when they take Aubagio and Reglan. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Aubagio?

Aubagio has active ingredients of teriflunomide. It is often used in multiple sclerosis. eHealthMe is studying from 50,041 Aubagio users. Check the latest studies of Aubagio.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

23 people who take Aubagio and Reglan together, and have interactions are studied.

What are the common drug interactions of Aubagio and Reglan, by gender? *:

female:

Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Gait disturbance
Somnolence (a state of near-sleep, a strong desire for sleep)
Urinary tract infection
Alopecia (absence of hair from areas of the body)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthma
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)

male:

n/a

What are the common drug interactions of Aubagio and Reglan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Muscle spasms (muscle contraction)
Peroneal nerve palsy
Abdominal pain
Asthenia (weakness)
Blood pressure decreased
Blood urine present
Constipation
Dizziness
Drug ineffective
Flushing (the warm, red condition of human skin)

40-49:

Alopecia (absence of hair from areas of the body)
Oropharyngeal pain
Rash

50-59:

Vomiting
Alopecia (absence of hair from areas of the body)
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Pneumonia
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Cough
Pyrexia (fever)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthenia (weakness)

60+:

Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Gait disturbance
Asthma
Bladder fibrosis (formation of excess fibrous connective tissue in bladder)
Chest discomfort
Colitis (inflammation of colon)
Cough
Cystitis interstitial (unknown cause characterized by bladder pain)
Discomfort
Dysphemia (stammering or stuttering)

What are the existing conditions these people have? *

Gait Disturbance: 4 people, 17.39%
Ill-Defined Disorder: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Aubagio and Reglan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously